India to United Kingdom: Gliclazide Export Trade Route
India has recorded 209 verified shipments of Gliclazide exported to United Kingdom, representing a combined trade value of $4.7M USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $22.4K USD. The leading Indian exporter is MEDREICH LIMITED, which accounts for 28% of total export value with 32 shipments worth $1.3M USD. On the buying side, MEDREICH PLC is the largest importer in United Kingdom with $1.3M USD in purchases. The top 3 suppliers — MEDREICH LIMITED, UNISON PHARMACEUTICALS PRIVATE LIMITED, MARKSANS PHARMA LIMITED — together control 67% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Gliclazide corridor is one of India's established pharmaceutical export routes, with 209 shipments documented worth a combined $4.7M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 28% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $22.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 22.6%, placing it at rank #5 among India's top gliclazide export destinations globally.
On the import side, key buyers of Indian gliclazide in United Kingdom include MEDREICH PLC, CRESCENT PHARMA LIMITED, MILPHARM LIMITED and 14 others. MEDREICH PLC is the single largest importer with 32 shipments valued at $1.3M USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#5
- Annual growth+22.6%
- Demand growth+21.0%
- Regulatory ease70/100
Top 10 Indian Gliclazide Exporters to United Kingdom
Showing top 10 of 15 Indian suppliers exporting Gliclazide to United Kingdom, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDREICH LIMITED Avg $40.9K per shipment | 32 | $1.3M | 27.9% |
| 2 | UNISON PHARMACEUTICALS PRIVATE LIMITED Avg $22.2K per shipment | 54 | $1.2M | 25.6% |
| 3 | MARKSANS PHARMA LIMITED Avg $46.5K per shipment | 14 | $651.2K | 13.9% |
| 4 | VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED Avg $13.9K per shipment | 33 | $458.8K | 9.8% |
| 5 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED Avg $24.7K per shipment | 10 | $247.4K | 5.3% |
| 6 | FLAMINGO PHARMACEUTICALS LIMITED Avg $37.4K per shipment | 6 | $224.6K | 4.8% |
| 7 | FOURRTS I LABORATORIES PRIVATE LIMITED Avg $37.2K per shipment | 4 | $149.0K | 3.2% |
| 8 | S KANT HEALTHCARE LIMITED Avg $27.9K per shipment | 4 | $111.7K | 2.4% |
| 9 | IPCA LABORATORIES LIMITED Avg $3.0K per shipment | 35 | $106.7K | 2.3% |
| 10 | FOURRTS I LABORATORIES PVT LTD Avg $16.3K per shipment | 6 | $97.7K | 2.1% |
This table shows the top 10 of 15 Indian companies exporting gliclazide to United Kingdom, ranked by total trade value. The listed exporters are: MEDREICH LIMITED, UNISON PHARMACEUTICALS PRIVATE LIMITED, MARKSANS PHARMA LIMITED, VERGO PHARMA RESEARCH LABORATORIES PRIVATE LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, FLAMINGO PHARMACEUTICALS LIMITED, FOURRTS I LABORATORIES PRIVATE LIMITED, S KANT HEALTHCARE LIMITED, IPCA LABORATORIES LIMITED, FOURRTS I LABORATORIES PVT LTD. MEDREICH LIMITED is the dominant supplier with 32 shipments worth $1.3M USD, giving it a 28% market share. The top 3 suppliers together account for 67% of the total trade value on this route.
Showing top 10 of 15 total Indian exporters on the India to United Kingdom Gliclazide export route.
Top 10 Gliclazide Importers in United Kingdom
Showing top 10 of 17 known buyers in United Kingdom receiving Gliclazide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian gliclazide in United Kingdom include MEDREICH PLC, CRESCENT PHARMA LIMITED, MILPHARM LIMITED, RELONCHEM LTD CHESHIRE HOUSE,, KEY PHARMACEUTICALS LTD, among 17 total buyers. The largest importer is MEDREICH PLC, accounting for $1.3M USD across 32 shipments — representing 28% of all gliclazide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDREICH PLC | 32 | $1.3M | 27.9% |
| 2 | CRESCENT PHARMA LIMITED | 54 | $1.2M | 25.6% |
| 3 | MILPHARM LIMITED | 18 | $469.6K | 10.0% |
| 4 | RELONCHEM LTD CHESHIRE HOUSE, | 10 | $461.0K | 9.8% |
| 5 | KEY PHARMACEUTICALS LTD | 12 | $238.2K | 5.1% |
| 6 | KEY PHARMACEUTICALS LIMITED | 21 | $220.6K | 4.7% |
| 7 | RELONCHEM LIMITED | 4 | $190.2K | 4.1% |
| 8 | XXAMIXXO PXXRMAXXUK)XXIMIXXD | 3 | $112.4K | 2.4% |
| 9 | FLAMINGO PHARMA UK LIMITED | 3 | $112.2K | 2.4% |
| 10 | TO THE ORDER | 4 | $111.7K | 2.4% |
Showing top 10 of 17 Gliclazide importers in United Kingdom on this route.
Top 10 Gliclazide Formulations Imported by United Kingdom
Showing top 10 of 151 product formulations shipped on the India to United Kingdom Gliclazide route, ranked by trade value
United Kingdom imports a wide range of gliclazide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GLICLAZIDE 40MG TABLETS 28'S — accounts for $224.6K USD across 6 shipments. There are 151 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLICLAZIDE 40MG TABLETS 28'S | 6 | $224.6K | 4.8% |
| 2 | GLICLAZIDE 80MG TABLETS 2X14S | 2 | $150.7K | 3.2% |
| 3 | PHARMACEUTICAL PRODUCTS - GLICLAZIDE 80MG TABLETS BATCH NO: 140353,140354 | 3 | $111.7K | 2.4% |
| 4 | HARMLESS MEDICINE -GLICLAZIDE 80MG TABLETS UNIT : 2X14 TAB | 3 | $111.7K | 2.4% |
| 5 | GLICLAZIDE TABLETS BP 80MG 2X14S (248220 PACKS) | 1 | $108.7K | 2.3% |
| 6 | GLICLAZIDE 80 MG TABLETS (GLICLAZIDE)(2X14T)BL(GLICLAZIDE)B.NO.2330948 TO 2330952,2330997,2331022,2331023 AS PER INVOICENOS | 3 | $108.2K | 2.3% |
| 7 | GLICLAZIDE TABLETS BP 80MG 2X14S (250310 PACKS)KGS | 1 | $107.2K | 2.3% |
| 8 | GLICLAZIDE TABLETS BP 80MG 2X14S (247670 PACKS) | 1 | $106.6K | 2.3% |
| 9 | GLICLAZIDE 80 MG TABLETS GLICLAZIDE 2 | 2 | $94.6K | 2.0% |
| 10 | GLICLAZIDE 80 MG TABLETS GLICLAZIDE BA | 2 | $94.5K | 2.0% |
Showing top 10 of 151 Gliclazide formulations imported by United Kingdom on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 42 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's gliclazide exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 32 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MEDREICH LIMITED, UNISON PHARMACEUTICALS PRIVATE LIMITED, MARKSANS PHARMA LIMITED — together account for 67% of total trade value on this route. The average shipment value of $22.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as gliclazide 80mg tablets 2x14s and pharmaceutical products - gliclazide 80mg tablets batch no: 140353,140354, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MEDREICH PLC is the largest importer with 32 shipments worth $1.3M USD — representing 28% of all gliclazide imports from India on this route. A total of 17 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.7M
- Avg. Shipment
- $22.4K
- Suppliers
- 15
- Buyers
- 17
- Transit (Sea)
- ~20 days
- Annual Growth
- +22.6%
Related Analysis
Reverse Direction
United Kingdom → India — Gliclazide (Import)Other Gliclazide Routes
Unlock the Full India to United Kingdom Gliclazide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 209 shipments on this route.
Frequently Asked Questions — India to United Kingdom Gliclazide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Gliclazide to United Kingdom?
The leading Indian exporters of Gliclazide to United Kingdom are MEDREICH LIMITED, UNISON PHARMACEUTICALS PRIVATE LIMITED, MARKSANS PHARMA LIMITED. MEDREICH LIMITED holds the largest market share at approximately 28% of total trade value on this route.
Q What is the total value of Gliclazide exports from India to United Kingdom?
India exports Gliclazide to United Kingdom worth approximately $4.7M USD across 209 recorded shipments. The average value per shipment is $22.4K USD.
Q Which ports does India use to ship Gliclazide to United Kingdom?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 42 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to United Kingdom for Gliclazide?
The average transit time for Gliclazide shipments from India to United Kingdom is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United Kingdom Gliclazide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.6% with demand growth tracking at 21.0%. The route is ranked #5 among India's top Gliclazide export destinations globally.
Q How many suppliers are active on the India to United Kingdom Gliclazide route?
There are currently 15 active Indian suppliers exporting Gliclazide to United Kingdom. The market is moderately concentrated with MEDREICH LIMITED accounting for 28% of total shipment value.
Q Who are the main importers of Gliclazide from India in United Kingdom?
The leading importers of Indian Gliclazide in United Kingdom include MEDREICH PLC, CRESCENT PHARMA LIMITED, MILPHARM LIMITED, RELONCHEM LTD CHESHIRE HOUSE,, KEY PHARMACEUTICALS LTD. MEDREICH PLC is the largest buyer with 32 shipments worth $1.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Kingdom export trade corridor identified from Indian Customs (DGFT) records for Gliclazide.
- 2.Supplier/Buyer Matching: 15 Indian exporters and 17 importers in United Kingdom matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 209 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
209 Verified Shipments
15 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists